scholarly article | Q13442814 |
P50 | author | John Hwa Lee | Q90115270 |
Jonathan Lalsiamthara | Q115075473 | ||
P2093 | author name string | Je Hyoung Kim | |
P2860 | cites work | One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products | Q27860842 |
Use of live bacterial vaccine vectors for antigen delivery: potential and limitations | Q31887727 | ||
Salmonella serosurveillance: different statistical methods to categorise pig herds based on serological data | Q33416275 | ||
Changes of physiological and biochemical properties of Salmonella enterica serovar Typhimurium by deletion of cpxR and lon genes using allelic exchange method | Q33510831 | ||
Statistical measurement of virulence and of immunity: application to the study of typhoid bacteria and to the measurement of immunizing power of antityphoid vaccines | Q41037214 | ||
Intermediate rough Brucella abortus S19Δper mutant is DIVA enable, safe to pregnant guinea pigs and confers protection to mice. | Q41337848 | ||
Impact of prior immunological exposure on vaccine delivery by Salmonella enterica serovar Typhimurium | Q44381786 | ||
Protective immunity against herpes simplex virus (HSV) type 1 following oral administration of recombinant Salmonella typhimurium vaccine strains expressing HSV antigens | Q45764942 | ||
Surface expression of malarial antigens in Salmonella typhimurium: induction of serum antibody response upon oral vaccination of mice | Q47872108 | ||
Oral Salmonella typhimurium vaccine expressing circumsporozoite protein protects against malaria | Q47910752 | ||
Immuno-profiles of BALB/c mice inoculated with Salmonella vector delivering B-cell mitogen hydroxyproline epimerase | Q49923998 | ||
Derepression of Salmonella pathogenicity island 1 genes within macrophages leads to rapid apoptosis via caspase-1- and caspase-3-dependent pathways | Q50094367 | ||
Salmonella vaccine carrier strains: effective delivery system to trigger anti-tumor immunity by oral route | Q50127302 | ||
Oral delivery of foreign antigens by attenuated Salmonella: consequences of prior exposure to the vector strain | Q50135609 | ||
Heterologous expression of the cuticular-glutathione peroxidase of lymphatic filariae in an attenuated vaccine strain of Salmonella typhimurium abrogates H-2 restriction of specific antibody responses | Q50138714 | ||
Virulence and vaccine potential of phoP mutants of Salmonella typhimurium | Q50195223 | ||
Brucella suis S2, brucella melitensis Rev. 1 and Brucella abortus S19 living vaccines: residual virulence and immunity induced against three Brucella species challenge strains in mice | Q68367993 | ||
Statistical procedures for calculating the residual virulence of Brucella abortus strain 19 (S19) and Brucella melitensis strain Rev 1 vaccines in mice: theoretical basis and practical applications | Q79746204 | ||
Controlling the maturation of pathogen-containing vacuoles: a matter of life and death | Q33772671 | ||
Physiology, pathogenicity and immunogenicity of lon and/or cpxR deleted mutants of Salmonella Gallinarum as vaccine candidates for fowl typhoid | Q33920959 | ||
Effect of preexisting immunity to Salmonella on the immune response to recombinant Salmonella enterica serovar typhimurium expressing a Porphyromonas gingivalis hemagglutinin | Q34004542 | ||
Salmonella Typhimurium LPS mutations for use in vaccines allowing differentiation of infected and vaccinated pigs | Q34171892 | ||
Development of a multiplex PCR technique for detection and epidemiological typing of salmonella in human clinical samples | Q34311887 | ||
Mucosal immunity and vaccines | Q34409172 | ||
Role of lipopolysaccharide susceptibility in the innate immune response to Salmonella typhimurium infection: LPS, a primary target for recognition of Gram-negative bacteria | Q34469773 | ||
Impact of vector priming on the immunogenicity of recombinant Salmonella vaccines | Q34531946 | ||
Enhancement of immune responses by an attenuated Salmonella enterica serovar Typhimurium strain secreting an Escherichia coli heat-labile enterotoxin B subunit protein as an adjuvant for a live Salmonella vaccine candidate | Q34738751 | ||
Oral immunization with an rfaH mutant elicits protection against salmonellosis in mice | Q34760019 | ||
Mucosal vaccination overcomes the barrier to recombinant vaccinia immunization caused by preexisting poxvirus immunity | Q35130248 | ||
Targeting tumors with salmonella Typhimurium- potential for therapy | Q35169604 | ||
Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shock | Q35176262 | ||
Effect of deletion of genes involved in lipopolysaccharide core and O-antigen synthesis on virulence and immunogenicity of Salmonella enterica serovar typhimurium | Q35273125 | ||
Oral vaccination with an attenuated Salmonella typhimurium strain expressing Borrelia burgdorferi OspA prevents murine Lyme borreliosis | Q35406291 | ||
Human papillomavirus type 16 virus-like particles expressed in attenuated Salmonella typhimurium elicit mucosal and systemic neutralizing antibodies in mice | Q35553171 | ||
Enteric pathogens as vaccine vectors for foreign antigen delivery | Q35896020 | ||
The role of host cell death in Salmonella infections. | Q36080758 | ||
Comparison between Immunization Routes of Live Attenuated Salmonella Typhimurium Strains Expressing BCSP31, Omp3b, and SOD of Brucella abortus in Murine Model | Q36814216 | ||
A live attenuated Salmonella Enteritidis secreting detoxified heat labile toxin enhances mucosal immunity and confers protection against wild-type challenge in chickens. | Q36969236 | ||
Salmonella typhimurium deletion mutants lacking adenylate cyclase and cyclic AMP receptor protein are avirulent and immunogenic | Q37009163 | ||
LAMP-3 (Lysosome-Associated Membrane Protein 3) Promotes the Intracellular Proliferation of Salmonella typhimurium | Q37121875 | ||
Engineering Salmonella as intracellular factory for effective killing of tumour cells. | Q37134828 | ||
Virulence Associated Genes-Deleted Salmonella Montevideo Is Attenuated, Highly Immunogenic and Confers Protection against Virulent Challenge in Chickens | Q37333735 | ||
An intermediate step in translocation of lipopolysaccharide to the outer membrane of Salmonella typhimurium | Q37604596 | ||
Pathogenic traits of Salmonella Montevideo in experimental infections in vivo and in vitro | Q37741324 | ||
Pre-existing immunity against vaccine vectors--friend or foe? | Q38061876 | ||
Engineered bacteria as therapeutic agents | Q38526395 | ||
Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines | Q39513114 | ||
The common mucosal immune system and current strategies for induction of immune responses in external secretions | Q39663021 | ||
Role of Salmonella enterica lipopolysaccharide in activation of dendritic cell functions and bacterial containment | Q39822002 | ||
Pathogenicity and protective effect of rough mutants of Salmonella species in germ-free piglets. | Q39831824 | ||
Inhibition of macrophage phagosome-lysosome fusion by Salmonella typhimurium | Q40150964 | ||
Brucella lipopolysaccharide reinforced Salmonella delivering Brucella immunogens protects mice against virulent challenge | Q40169281 | ||
Phagolysosome Formation, Cyclic Adenosine 3':5'-Monophosphate and the Fate of Salmonella typhimurium within Mouse Peritoneal Macrophages | Q40225458 | ||
Evaluation of safety and protection efficacy on cpxR and lon deleted mutant of Salmonella Gallinarum as a live vaccine candidate for fowl typhoid | Q40342233 | ||
P433 | issue | 39 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Salmonella Typhimurium | Q166491 |
P304 | page(s) | 25441-25457 | |
P577 | publication date | 2018-05-22 | |
P1433 | published in | Oncotarget | Q1573155 |
P1476 | title | Engineering of a rough auxotrophic mutant Salmonella Typhimurium for effective delivery. | |
P478 | volume | 9 |
Q92886267 | Live vaccine consisting of attenuated Salmonella secreting and delivering Brucella ribosomal protein L7/L12 induces humoral and cellular immune responses and protects mice against virulent Brucella abortus 544 challenge |
Q91129598 | Partial protection induced by Salmonella based Brucella vaccine candidate in pregnant guinea pigs |
Search more.